PURPOSE: To examine the impact of new controlled drugs legislation introduced in May 2017 on benzodiazepine receptor agonist (BZRA) prescribing in Ireland. METHODS: A repeated cross-sectional analysis was conducted using publically available monthly pharmacy claims data from the General Medical Services (GMS) database. The study population comprised all GMS-eligible individuals aged ≥ 16 years from January 2016 to September 2019. Monthly prevalence rates of individuals receiving BZRA prescriptions per 10,000 eligible population were calculated and trends examined over time. Segmented linear regression of prevalence rates was used to examine changes before and after introduction of the legislation stratified by gender and age groups. Regression coefficients (β) and 95% confidence intervals (CIs) for monthly change were calculated. RESULTS: Pre-legislation (January 2016 to April 2017), there was a significant monthly decline in benzodiazepine prevalence rate (β = - 1.18; 95% CI - 1.84, - 0.51; p < 0.001) but no significant change in Z-drug prescribing. Post-legislation (May 2017 to September 2019), increases in prevalence rates were observed for benzodiazepines (β = 1.04; 95% CI 0.17, 1.92; p = 0.021) and Z-drugs (β = 1.04; 95% CI 0.26, 1.83; p = 0.010). Post-legislation trends showed increases in BZRA prevalence rates among the youngest subgroup (16-44 years), with variable changes in the middle-aged subgroup (45-64 years) and no changes in the oldest subgroup (≥ 65 years). CONCLUSIONS: This study indicates that introduction of new legislation had limited impact on BZRA prescribing on the main public health scheme in Ireland. Interventions targeting specific population subgroups may be required to achieve sustained reductions in prescribing.
Soyka M (2017) Treatment of benzodiazepine dependence. N Engl J Med. 376(12):1147–1157
[PMID: 28328330]
Krystal AD, Prather AA, Ashbrook LH (2019) The assessment and management of insomnia: an update. World Psychiatry. 18(3):337–352
[PMID: 31496087]
Schifano F, Chiappini S, Corkery JM, Guirguis A (2019) An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines Agency database of suspected adverse drug reactions. Int J Neuropsychopharmacol. 22(4):270–277
[PMID: 30722037]
Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B (2018) Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 64(5):339–351
[PMID: 29760253]
Davies J, Rae TC, Montagu L (2017) Long-term benzodiazepine and Z-drugs use in the UK: a survey of general practice. Br J Gen Pract 67(662):609–613
[DOI: 10.3399/bjgp17X691865]
Olfson M, King M, Schoenbaum M (2015) Benzodiazepine use in the United States. JAMA Psychiatry. 72(2):136–142
[PMID: 25517224]
Cadogan CA, Ryan C, Cahir C, Bradley CP, Bennett K (2018) Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. Br J Clin Pharmacol. 84(6):1354–1363
[PMID: 29488252]
Benzodiazepine Committee (2002) Report of the Benzodiazepine Committee Dublin. Ireland, Department of Health and Children Available at http://www.drugsandalcohol.ie/5348/ (last accessed 15 April 2020)
Benzodiazepine Committee (2002) Benzodiazepines: good practice guidelines for clinicians. Dublin, Department of Health and Children Available at http://www.drugsandalcohol.ie/5349/ (last accessed 15 April 2020)
Flynn K (2009) Minor tranquillisers and sedatives: use and misuse in the West of Ireland. Galway, Western Region Drugs Task Force Available at http://www.drugsandalcohol.ie/11506/ (last accessed 15 April 2020)
Henman M, Vivero L, Gustafsson A, Mulvenna K (2004) Benzodiazepine usage in the North Eastern Health Board region of the Republic of Ireland, Trinity College Dublin Available at http://www.drugsandalcohol.ie/12669/ (last accessed 15 April 2020)
Brandt J, Leong C (2017) Benzodiazepines and Z-Drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 17(4):493–507
[PMID: 28865038]
Government of Ireland. Statutory Instrument No. 173/2017 — Misuse of Drugs Regulations, 2017. Dublin, Ireland. Available from: http://www.irishstatutebook.ie/eli/2017/si/173/made/en/print (last accessed 15 April 2020)
Sinnott SJ, Bennett K, Cahir C (2017) Pharmacoepidemiology resources in Ireland-an introduction to pharmacy claims data. Eur J Clin Pharmacol. 73(11):1449–1455
[PMID: 28819675]
Health Service Executive (2018) Primary Care Reimbursement Service: statistical analysis of claims and payments 2018. Health Service Executive, Dublin Available at https://www.hse.ie/eng/staff/pcrs/pcrs-publications/annual-report-2018.pdf (last accessed 15 April 2020)
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment Oslo, Norway; 2012. Available at https://www.drugsandalcohol.ie/29364/ (last accessed 15 April 2020)
Ashton H (2002) Benzodiazepines: how they work and how to withdraw (also known as The Ashton Manual): University of Newcastle, England. Available at http://www.benzo.org.uk/manual/index.htm (last accessed 15 April 2020)
Passaro A, Volpato S, Romagnoni F, Manzoli N, Zuliani G, Fellin R (2000) Benzodiazepines with different half-life and falling in a hospitalized population: The GIFA study. Gruppo Italiano di Farmacovigilanza nell'Anziano. J Clin Epidemiol. 53(12):1222–1229
[PMID: 11146268]
Brandt J, Alkabanni W, Alessi-Severini S, Leong C (2018) Translating benzodiazepine utilization data into meaningful population exposure: integration of two metrics for improved reporting. Clin Drug Investig. 38(7):565–572
[PMID: 29619753]
Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 27(4):299–309
[PMID: 12174032]
Davies SJC, Jacob B, Rudoler D, Zaheer J, de Oliveira C, Kurdyak P (2018) Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013. Ther Adv Psychopharmacol. 8(3):99–114
[PMID: 29492258]
Fox R, Beeching NJ, Morrison C, Ruben S, Garvey T (1992) Misuse of temazepam. BMJ. 305(6847):253
[PMID: 1392842]
Strang J, Seivewright N, Farrell M (1992) Intravenous and other novel abuses of benzodiazepines: the opening of Pandora's box? Br J Addict. 87(10):1373–1375
[PMID: 1358296]
Irish Medical Organisation (2013) IMO Submission to the Department of Health on the Draft Misuse of Drugs (Amendment) Regulations 2013. Available from: https://www.imoie/policy-international-affair/documents/imo-submissions-to-external-bodies/draft-misuse-of-drugs-(am/IMO-Sub-on-Draft-Misuse-of-Drugs-Regulations-FinalpdfPDF . (last accessed 15 April 2020)
Manders L, Abd-Elsayed A (2020) Mandatory review of prescription drug monitoring program before issuance of a controlled substance results in overall reduction of prescriptions including opioids and benzodiazepines. Pain Physician. 23(3):299–304
[PMID: 32517396]
Department of Health (Ireland) (2019) National Healthcare Quality Reporting System Annual Report. Ireland. Available from: https://www.gov.ie/en/collection/5fd4f6-national-healthcare-quality-reporting-system-reports/ (last accessed 15 April 2020)
American Geriatrics Society (2015) American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 63(11):2227–2246
[DOI: 10.1111/jgs.13702]
By the American Geriatrics Society Beers Criteria Update Expert P (2019) American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 67(4):674–694
[DOI: 10.1111/jgs.15767]
Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D (2008) STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 46(2):72–83
[PMID: 18218287]
O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 44(2):213–218
[PMID: 25324330]
Alessi-Severini S, Bolton JM, Enns MW, Dahl M, Collins DM, Chateau D, Sareen J (2014) Use of benzodiazepines and related drugs in Manitoba: a population-based study. CMAJ Open. 2(4):E208–E216
[PMID: 25485245]
Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R (2016) Trends in prescribing of sedative-hypnotic medications in the USA: 1993-2010. Pharmacoepidemiol Drug Saf. 25(6):637–645
[PMID: 26711081]
Sidorchuk A, Isomura K, Molero Y, Hellner C, Lichtenstein P, Chang Z, Franck J, Fernández de la Cruz L, Mataix-Cols D (2018) Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study. PLoS Med. 15(8):e1002635
[PMID: 30086134]
Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H, Miret M, Schneider C, Gil M, Souverein PC, de Bruin ML, Slattery J, de Groot MCH, Hesse U, Rottenkolber M, Schmiedl S, Montero D, Bate A, Ruigomez A, García-Rodríguez LA, Johansson S, de Vries F, Schlienger RG, Reynolds RF, Klungel OH, de Abajo FJ (2016) Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. 25(1):56–65
[PMID: 26149383]
Cannon M, Coughlan H, Clarke M, Harley M, Kelleher I The mental health of young people in Ireland: a report of the Psychiatric Epidemiology Research across the Lifespan (PERL) Group Dublin. Royal College of Surgeons of Ireland, Dublin Available from: https://www.drugsandalcohol.ie/20687/ (last accessed 15 April 2020)
O'Doherty J, Hannigan A, Hickey L, Meagher D, Cullen W, O'Connor R et al (2018) The prevalence and treatment of mental health conditions documented in general practice in Ireland. Ir J Psychol Med. 37(1):1–8
McMahon J, Ryan F, Cannon M, O'Brien G, O'Callaghan M, Flanagan R et al (2019) Where next for youth mental health services in Ireland? Ir J Psychol Med. 36(3):163–167
[PMID: 31524127]
Byers V (2017) Health Care for All in Ireland? The Consequences of Politics for Health Policy. World Med Health Policy. 9(1):138–151
[DOI: 10.1002/wmh3.217]
J P. The Future of Healthcare in Ireland: position paper on the health crisis and the government’s plans for healthcare. Ireland. Available from: https://www.semanticscholar.org/paper/The-future-of-healthcare-in-Ireland-Position-paper-Pillinger/6cea9d4073748ef5d31004e5b9fd37ba384c8ae4#citing-papers (last accessed 15 April 2020).
Health Service Executive - National Counselling Service - CIPC National Research Group. Counselling in Primary Care Service, National Evaluation Study, Phase 1. 2018. Dublin: Health Service Executive: https://www.hse.ie/eng/services/list/4/mental-health-services/counsellingpc/cipc-national-evaluation/hse-ncs-counselling-in-primary-care-national-evaluation-study-report-of-phase-1-april-2018.pdf ; (last accessed 15 April 2020)
Rafferty M, Bradley C (2019) Counselling in primary care - a general practitioner’s perspective. Ir Med J. 112(2):869
[PMID: 30892002]
Donoghue J, Lader M (2010) Usage of benzodiazepines: a review. Int J Psychiatry Clin Pract. 14(2):78–87
[PMID: 24922466]
Medicines Management Programme. Guidance on appropriate prescribing of benzodiazepines and z-drugs (BZRA) in the treatment of anxiety and insomnia. 2018. Ireland: Health Services Executive. Available from: https://www.hse.ie/eng/about/who/cspd/ncps/medicines-management/bzra-for-anxiety-insomnia/bzraguidancemmpfeb18.pdf (last accessed 15 April 2020).
Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN (2013) General practitioners' experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Family Pract. 14:191
[DOI: 10.1186/1471-2296-14-191]
Shaw J, Murphy AL, Turner JP, Gardner DM, Silvius JL, Bouck Z, Gordon D, Tannenbaum C (2019) Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults. Healthc Policy. 14(4):39–51
[PMID: 31322113]
Pollmann AS, Murphy AL, Bergman JC, Gardner DM (2015) Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol. 16:19
[PMID: 26141716]
Lynch T, Ryan C, Hughes CM, Presseau J, van Allen ZM, Bradley CP et al (2020) Brief interventions targeting long-term benzodiazepine and Z-drug use in primary care: a systematic review and meta-analysis. Addiction. 115(9):1618–1639
[PMID: 31985127]
Fisher J, Sanyal C, Frail D, Sketris I (2012) The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. J Clin Pharm Ther. 37(1):7–21
[PMID: 21332565]
